HOME >> BIOLOGY >> NEWS
Sandia Decontamination Foam May Be Tomorrow's Best First Response In A Chem-Bio Attack

ALBUQUERQUE, N.M. -- Emergency personnel responding to a terrorist release of chemical or biological warfare agents will be faced with a dilemma: If they enter the scene without knowing the dangers, they might become a victim. If they wait to evaluate, more people might die -- or worse, an agent could spread and cause widespread casualties.

A better option may be available soon. Researchers at the Department of Energy's Sandia National Laboratories have created a foam that begins neutralizing both chemical and biological agents in minutes. Because it is not harmful to people, it could be dispensed on the disaster scene immediately, even before casualties are evacuated.

Its developers think the decontaminating foam soon may be the best first response available in the event of a chem-bio attack.

"Whatever you do, it's best to act very quickly," says co-developer Maher Tadros of Sandia. "This foam can start neutralizing an agent or combinations of agents right away, even before you know what you're dealing with."

The U.S. has a number of strategies to deter a chemical or biological attack from ever occurring in this country, says Greg Thomas, Sandia program manager for chem-bio nonproliferation. "But if we are attacked," he says, "we'll need to have the tools available to respond."

One decontaminant, all chem-bio agents
In laboratory tests at Sandia the foam destroyed simulants of the most worrisome chemical agents (VX, mustard, and soman) and killed a simulant of anthrax -- the toughest known biological agent.

Against the anthrax simulant, the foam achieved what the researchers call a 7-log kill -- after one hour only one anthrax spore out of 10 million is still alive.

International law prohibits the Sandia researchers from possessing real chemical or biological agents, but they have taken samples of the foam to the Illinois Institute of Technology in Chicago where the foam was tested against actual VX, mustard gas, and som
'"/>

Contact: john german
jdgerma@sandia.gov
505-844-5199
DOE/Sandia National Laboratories
2-Mar-1999


Page: 1 2 3 4

Related biology news :

1. Sandia experiments may reduce possibility of future water wars
2. $6 million appropriation to focus Sandia research on drinking water desalination, removal of arsenic
3. Sandia-aided method to heal wounded and diseased achieves US government acceptance
4. Sandia pursues biotechnology as new technology focus area
5. Sandia-developed formulation among products selected to help rid U.S. facilities of anthrax
6. Sandia portable chemical sensor system promises new way of detecting underwater explosives
7. Sandia-developed remote sensor expected to analyze gases up to two miles away
8. Sandia, University Of Montana Researchers Try Training Bees To Find Buried Landmines
9. Sandia Discovery About Protein May Help Clean Up Pollutants, Find Cures For Diseases
10. Improved Oxygen Bath To Heal Wounds, Lessen Number Of Amputations: Sandia To Sign Agreement With Numotech To Help Create Home-Use Healing Facility
11. Tracking Hepatitis C: Health Project Demos Worldwide Early-Warning System For Disease Outbreaks; Sandia Tests Disease-Tracking Approach

Post Your Comments:
(Date:5/22/2013)... important new details on how climate change will affect ... in the Journal of Animal Ecology . This ... and informing policymakers of how species are likely to ... is a growing recognition among biologists that climate change ... that this is going to have very important consequences ...
(Date:5/22/2013)... May 22, 2013. Plastic additives known as phthalates ... everywhere: They turn up in flooring, plastic cups, ... the Centers for Disease Control and Preventionthe bodies ... have come under increasing scrutiny. A growing collection ... can leech from packaging and mix with food) ...
(Date:5/21/2013)... "place" is increasingly being considered in the management ... new resource that can help them recognize and ... places in their lives. , Place-Based Conservation: ... co-edited by the Pacific Northwest Research Station,s Linda ... to conservation. The book is published by Springer ...
Breaking Biology News(10 mins):UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5Study links chemicals widely found in plastics and processed food to elevated blood pressure in children and teens 2
(Date:5/21/2013)... OXFORD, England , May 22, 2013 ... inhaled, novel drug-only formulation of glycopyrronium bromide designed using ... speciality pharmaceutical company developing a portfolio of inhaled ... 2 clinical study with PSX1002 that will assess its ... range of doses in patients with moderate to severe ...
(Date:5/21/2013)...  The Lindsley F. Kimball Research Institute of the New ... Grand Challenges Explorations winner, an initiative funded by the ... Sara Lustigman , Head of the Laboratory of Molecular ... project, titled Innovative 3-D in vitro culturing ... screen drugs to help eliminate onchocerciasis (river blindness) in ...
(Date:5/21/2013)... Through science fairs, workshops, kits for building ... 25 organizations will continue their work to increase awareness ... in daily life with the aid of SPIE ... 10 countries, are the first of two groups of ... the international society for optics and photonics , in ...
(Date:5/21/2013)... 2013 Alpha Source, Inc., a ... be exhibiting for the 13th consecutive year at ... (AAMI) 2013 Conference and Expo. The conference brings ... manufacture healthcare technologies. This year’s event will be ... , The three-day event draws over 1,500 ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 2New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 3Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2
Cached News: